MedPath

Evaluation of dizziness in patients with unilateral vestibular schwannoma (brughoektumor)

Recruiting
Conditions
nilateral vestibular schwannoma
Registration Number
NL-OMON27070
Lead Sponsor
MC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

Aged 18 or older, being diagnosed with unilateral vestibular schwannoma, follow-up including either surgery, radiotherapy or active surveillance, able to provide a written informed consent.

Exclusion Criteria

Active additional neuro-otologic disorders, severe disability (e.g. neurological, cardiovascular, orthopedic, psychiatric), serious concurrent illness that might interfere with vestibular evaluation, patients under medical treatment that affects vestibular function.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The vestibular function relating results to surgery, radiotherapy and active surveillance based on objective vestibular testing and dizziness related QoL
Secondary Outcome Measures
NameTimeMethod
The correlation between the objective vestibular test results and dizziness related symptoms with patients characteristics in each treatment modality.
© Copyright 2025. All Rights Reserved by MedPath